1. Investigation into scPharmaceuticals' sale to MannKind for $5.35 per share opened. 2. Shareholders may receive additional cash based on regulatory milestones. 3. Concerns exist over potential undervaluation for shareholders. 4. Halper Sadeh seeks to ensure fair treatment of investors. 5. Legal actions may demand better disclosures and valuation.
Valuation concerns and legal investigations could lower investor confidence, similar to past merger disputes.
Legal scrutiny can affect current and future stock prices; immediate investor concern is evident.
Immediate reactions to news often cause quick price fluctuations but could stabilize with time.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of scPharmaceuticals Inc. (NASDAQ:SCPH) to MannKind Corporation is fair to scPharmaceuticals shareholders. Under the terms of the proposed transaction, scPharmaceuticals shareholders would receive a cash payment of $5.35 per share plus one non-tradable contingent value right (CVR) per share payable upon achieving specific regulatory and net sales milestones worth up to $1.00 per CVR in cash.
Halper Sadeh encourages scPharmaceuticals shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.
The investigation concerns whether scPharmaceuticals and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for scPharmaceuticals shareholders; (2) determine whether MannKind is underpaying for scPharmaceuticals; and (3) disclose all material information necessary for scPharmaceuticals shareholders to adequately assess and value the merger consideration.
On behalf of scPharmaceuticals shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250825799079/en/
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com